Optimizing the management of HER2-positive early breast cancer: the clinical reality.
Verma S, Lavasani S, Mackey J, Pritchard K, Clemons M, Dent S, Latreille J, Lemieux J, Provencher L, Verma Sh, Chia S, Wang B, Rayson D.
Verma S, et al. Among authors: provencher l.
Curr Oncol. 2010 Aug;17(4):20-33. doi: 10.3747/co.v17i4.700.
Curr Oncol. 2010.
PMID: 20697511
Free PMC article.